2022
DOI: 10.1039/d2ob00862a
|View full text |Cite
|
Sign up to set email alerts
|

Vinyl azide as a synthon for DNA-compatible divergent transformations into N-heterocycles

Abstract: We have developed a series of DNA-compatible N-heterocycle formation methods utilizing on-DNA vinyl azide as a synthon to obtain two kinds of poly-substituted imidazoles and isoquinolines.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 58 publications
0
2
0
Order By: Relevance
“…Attracted by the DEL's cost and time efficiency, both academia and pharmaceutical companies have advanced DEL in terms of synthetic methodology and selection strategy. [18][19][20][21][22][23][24][25][26][27][28][29][30][31] Currently, although very few drug candidates in late-stage clinical trials stemmed from DEL, such as the soluble epoxide hydrolase (sEH) inhibitor GSK2256294 and the receptor-interacting protein (RIP1) kinase inhibitor GSK2982772, [32][33][34][35] DELs have shown their potential in high-throughput discovery of preliminary bioactive hits for dened targets, which might lead to the development of bioactive compounds or probes with structural optimization.…”
Section: Introductionmentioning
confidence: 99%
“…Attracted by the DEL's cost and time efficiency, both academia and pharmaceutical companies have advanced DEL in terms of synthetic methodology and selection strategy. [18][19][20][21][22][23][24][25][26][27][28][29][30][31] Currently, although very few drug candidates in late-stage clinical trials stemmed from DEL, such as the soluble epoxide hydrolase (sEH) inhibitor GSK2256294 and the receptor-interacting protein (RIP1) kinase inhibitor GSK2982772, [32][33][34][35] DELs have shown their potential in high-throughput discovery of preliminary bioactive hits for dened targets, which might lead to the development of bioactive compounds or probes with structural optimization.…”
Section: Introductionmentioning
confidence: 99%
“…[26][27][28][29][30] Numerous reaction toolkits, which must be DNA-compatible, have been thereby developed and employed to construct encoded libraries, and the building blocks (BBs) for library construction should be conveniently accessible or commercially available to expand the chemical diversities to more complicated molecular architectures beyond encoding early-stage peptide-like libraries. [31][32][33] Therefore, there is an imminent need for incorporation of NPs with rich chemical diversities into DELs.…”
mentioning
confidence: 99%